Feed XCUR
XC

Exicure, Inc. XCUR NASDAQ · Healthcare · United States

$1.08 +0.93% +$0.01

Market cap
$7.07M
Enterprise value
$5.35M
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/FCF
-
EV/EBITDA
-
ROIC
-93.9%
Gross margin
-
Net margin
-
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
3.74
Free float
28.1%

About the company

Exicure, Inc. is a biopharmaceutical company focused on developing novel therapeutics based on the technology of therapeutic coding. Its main product platform is based on a technology called Spherical Nucleic Acid (SNA™), which enables the creation of three-dimensional structures of nucleic acids that have the potential to modulate gene expression. Exicure aims to utilize this technology to develop therapeutics for various indications, including oncological diseases, dermatological conditions, and neurological disorders. The company also engages in research and development of therapeutic vaccines based on SNA™ technology. Exicure collaborates with pharmaceutical companies and academic institutions on the development and commercialization of its products. Shares of Exicure, Inc. may be an interesting investment opportunity for investors following the pharmaceutical industry and biopharmaceutical research.

Sector

Healthcare

Industry

Biotechnology

CEO

Jungsoo Kim

Employees

1

Headquarters

Redwood City

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

  • What speaks for it: It has no debt and holds $1.72M in cash.
  • What to watch: It passes only 1 of the 9 points of the Piotroski financial health test.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

  • What to watch: The price moves much more than the market (beta 3.74).

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy